HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Allan Andersen Selected Research

AD 20 (AD-20)

1/2013Binary classification of ¹⁸F-flutemetamol PET using machine learning: comparison with visual reads and structural MRI.
9/201018F-flutemetamol amyloid imaging in Alzheimer disease and mild cognitive impairment: a phase 2 trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Allan Andersen Research Topics

Disease

2Alzheimer Disease (Alzheimer's Disease)
01/2013 - 09/2010
2Cognitive Dysfunction
01/2013 - 09/2010
1Alcoholism (Alcohol Abuse)
09/2021
1Marijuana Abuse (Cannabis Abuse)
04/2009

Drug/Important Bio-Agent (IBA)

2NicotineFDA Link
09/2021 - 04/2009
2AD 20 (AD-20)IBA
01/2013 - 09/2010
1Amyloid (Amyloid Fibrils)IBA
09/2010